Anthony Klinkatsis

Sep 24, 2024 | ajp.com.au | Megan Haggan |Paul Sapardanis |Anthony Klinkatsis |Benjamin Kop

Stakeholders are marking World Pharmacists’ Day by highlighting evolving roles and supporting current ones This year’s theme is “Pharmacists: Meeting global health needs”. Pharmaceutical Society of Australia national president Associate Professor Fei Sim said that the future PSA sees further harnesses the potential of pharmacists. “Australians need the expertise of pharmacists more than ever before,”This content is restricted to registered users only.

Oct 31, 2023 | ajp.com.au | Nicholas O’Donoghue |Anthony Zehetner |Anthony Klinkatsis |William Stevenson

Overseas registered amoxicillin and clavulante potassium product, Aurobindo 50mL, will be a-flagged to Curam Duo 60mL on the PBS   Pharmacists can now fill prescriptions for amoxicillin 400 mg/5 mL + clavulanic acid 57 mg/5 mL powder for oral liquid, using either Curam Duo or Aurobindo, with both brands funded under the Pharmaceutical Benefits SchemeThis content is restricted to registered users only.

Oct 27, 2023 | ajp.com.au | Megan Haggan |Anthony Klinkatsis |Pauline Pilgrim |Russell Smith

Labor and Health have been grilled over 60-day dispensing, while there's scope of practice news in some states and new figures on pharmacist burnout It's been an interesting week in Canberra, as Senator Anne Ruston demanded answers on 60-day dispensing, hearing from Health's Penny Shakespeare on how the modelling was derived; from Labor's Katy GallagherThis content is restricted to registered users only.

Aug 9, 2023 | ajp.com.au | Nicholas O’Donoghue |Anthony Klinkatsis |Paul Sapardanis |Megan Haggan

Moves to stall the introduction of double dispensing will not be backed by the Australian Greens  The Australian Greens will not support a motion to disallow 60-day dispensing, the party’s health spokesperson, Senator Jordon Steele-John says. In a statement released this afternoon, Steele-John said the party supported the government’s efforts to deliver cheaper medicines forThis content is restricted to registered users only.

Jun 30, 2023 | ajp.com.au | Anthony Klinkatsis |James Tsaoucis |Bob Tran |Nicholas O’Donoghue

Allergic rhinitis (AR) or hayfever, is common, affecting one in five Australians.1 AR is a genuine health condition and should not be trivialised. It can significantly impact quality of life,2 therefore appropriate management is paramount. Self-medication is common,2 and 85% of people fail to select optimal treatment.3 Guidelines recommend intranasal corticosteroid sprays (INCS), such asThis content is restricted to registered users only.